Browsing: GLP-1
Investor optimism about the pill version of weight-loss injectables being developed by Sam Chun Dang Pharm (SCD) in South Korea…
This week delivered a sobering reminder that Alzheimer’s disease continues to defy even the most sophisticated scientific strategies. Within 24…
Injectable glucagon-like peptide-1 agonists, or GLP-1s, were first approved as diabetes medications 20 years ago. They’ve since become popular as…
You may have heard of “Ozempic mouth”, “Ozempic tongue” and “Ozempic penis.” Well, here’s yet another “O” body part term…
Wisp, the largest women’s telehealth platform in the U.S., launches at-home STI testing and GLP-1-based weight care—advancing its virtual women’s…
You may have heard of “Ozempic face”, “Ozempic butt” and “Ozempic finger,” three things that I have written about previously…
Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is quickly emerging as…
A commercial airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the…
Despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, fewer than one in five large employers…
At least two in five U.S. adults — or more than 57 million people – under the age of 65…